INSTITUT CATALA D'ONCOLOGIA - Spain 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:800-900
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:800-900
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 24
As coordinator: 2
As participant: 21
Sole participant: 1
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 13.500.063 493.750 2
2022 0 17.270.727 110.000 2
2021 0 7.148.388 138.000 2
2020 0 24.791.963 1.219.017 3
2019 0 9.152.900 446.420 2
2018 0 5.156.199 48.566 1
2017 0 9.995.146 108.403 1
2016 0 5.922.102 373.307 3
2015 2.987.794 5.996.992 1.429.370 1 1
2013 230.390 5.991.528 905.390 1 1
2012 0 1.495.796 1.495.796 1
2011 223.670 2.999.946 424.628 1 1
2010 0 2.963.532 390.302 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE6
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON6
DEUTSCHES KREBSFORSCHUNGSZENTRUM5
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT CURIE4
UNIVERSITA DEGLI STUDI DI TORINO4
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
EUROPEAN NETWORK FOR SMOKING PREVENTION3
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI3
ISTITUTO EUROPEO DI ONCOLOGIA3
KAROLINSKA INSTITUTE3
PANEPISTIMIO KRITIS3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA2
ASOCIATA AER PUR ROMANIA2
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES2
CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD2
CENTRE DE REGULACIO GENOMICA2
CENTRE REGIONAL DE LUTTE CONTRE LE CANCER HENRI BECQUEREL ROUEN2
EUROPEAN MOLECULAR BIOLOGY LABORATORY2
FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA2
FUNDACIO INSTITUT DE RECERCA BIOMEDICA2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
INSTITUT GUSTAVE ROUSSY2
INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE2
INSTYTUT MEDYCYNY PRACY IMIENIA PROF DRA MED JERZEGO NOFERA W LODZI2
KATHOLIEKE UNIVERSITEIT LEUVEN2
KLINIKUM DER UNIVERSITAET ZU KOELN2
MASARYKOVA UNIVERZITA2
NARODOWY INSTYTUT ONKOLOGII IM MARII SKLODOWSKIEJCURIE PANSTWOWY INSTYTUT BADAWCZY2
REGION STOCKHOLM2
STICHTING VUMC2
THE UNIVERSITY OF MANCHESTER2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAETSKLINIKUM HEIDELBERG2
UNIVERSITY OF BRISTOL2
UNIVERSITY OF TAMPERE2
UNIVERZA V LJUBLJANI2
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGENCIA DE SALUT PUBLICA DE BARCELONA1
AGENDIA NV1
AGENZIA NAZIONALE PER I SERVIZI SANITARI REGIONALI1
ALIRA HEALTH SL1
ALLEANZA CONTRO IL CANCRO1
ALTHAIA XARXA ASSISTENCIAL UNIVERSITARIA DE MANRESA FUNDACIO PRIVADA1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ASOCIATIA MELANOM ROMANIA1
ASSOCIACAO FEMININA DE EDUCACAO E COMBATE AO CANCER1
ASSOCIACAO PARA INVESTIGACAO E DESENVOLVIMENTO DA FACULDADE DE MEDICINA1
ATHENA TECH SL1
AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA1
AZIENDA OSPEDALIERA SAN GIOVANNI BATTISTA DI TORINO1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BCOM1
BEDIN SARA1
BELGISCHE VERENIGING VOOR MEDISCHE ONCOLOGIE / SOCIETE BELGE D ONCOLOGIE MEDICALE/ BELGIAN SOCIETY OF MEDICAL ONCOLOGY1
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM1
CARA TECHNOLOGY LIMITED1
CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CENTRO DE INVESTIGACION BIOMEDICA EN RED1
CENTRO HOSPITALAR DE SAO JOAO EPE1
CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III1
CHARLES UNIVERSITY PRAGUE1
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
DANISH CANCER SOCIETY1
DE CLERCQ & PARTNERS1
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG1
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG1
DIGESTIVE CANCERS EUROPE DICE1
DOHANYZAS VAGY EGESZSEG MAGYAR ALAPITVANY1
EIBIR GEMEINNUETZIGE GMBH ZUR FOERDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN ASSOCIATION FOR CANCER RESEARCH1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN CERVICAL CANCER ASOCIATION1
EUROPEAN HEALTH MANAGEMENT ASSOCIATION1
EUROPEAN LUNG FOUNDATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
EUROPEAN RESPIRATORY SOCIETY1
EUROPEAN SOCIETY OF GYNAECOLOGICAL1
FUNDACAO ANTONIO PRUDENTE1
FUNDACAO PIO XII1
FUNDACIO MUTUA DE TERRASSA PER A LA DOCENCIA I RECERCA BIOMEDICA I SOCIAL FUNDACIO PRIVADA CATALANA1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
FUNDACION CIENTIFICA DE LA ASOCIACION ESPANOLA CONTRA EL CANCER1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL GREGORIO MARANON1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PRINCESA1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL1
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA1
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA1
FUNDACION PUBLICA ANDALUZA PARA LAGESTION DE LA INVESTIGACION EN SALUD DE SEVILLA1
FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD MP1

Constancy:

Total number of partners: 296
Partner loyalty:
Frequent Partner: (> 2 projects): 58
Rare Partner: 238
Frequent / Rare Partner Ratio: 0.24

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Discovering the causes of three poorly understood cancers in Europe DISCERNparticipant8.857.81320
2023-01-01CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE PREVENTABLEparticipant4.642.25015
2022-12-01Novel health care strategies for melanoma in children, adolescents and young adults MELCAYAparticipant8.013.21925
2022-11-01Data-driven cancer genome interpretation for personalised cancer treatment CGI-Clinicsparticipant9.257.50817
2021-06-01Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. RESILIENCEparticipant5.998.38818
2021-06-01European Regulatory Science on Tobacco - Research and Innovation Staff Exchange EUREST-RISEparticipant1.150.0009
2020-01-01NGS diagnostics in 21st century oncology: the best, for all, at all times oncNGSparticipant10.999.65918
2020-01-014-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening 4-IN THE LUNG RUNparticipant7.999.94910
2020-01-01RISK-BASED SCREENING FOR CERVICAL CANCER RISCCparticipant5.792.35511
2019-01-01EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. EUCANCanparticipant5.999.45318
2019-01-01Translational studies of HEAD and neck cancer in South America and Europe HEADSpAcEparticipant3.153.44818
2018-02-01EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts EDIReXparticipant5.156.19919
2017-06-01Implications of Medical Low Dose Radiation Exposure MEDIRADparticipant9.995.14635
2016-09-01ANTI-SUPERBUG Precommercial procurement ANTI-SUPERBUGS PCPparticipant3.446.62510
2016-09-01Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer - AngioResist AngioResistparticipant149.9321
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2015-11-01Tackling secondhand tobacco smoke and e-cigarette emissions: exposure assessment, novel interventions, impact on lung diseases and economic burden in diverse European populations. The TackSHS Project. TackSHScoordinator2.987.79412
2015-10-01Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor) MoTriColorparticipant5.996.99211
2013-11-01Comparing health services interventions for the prevention of HPV-related cancer COHEAHRparticipant5.991.52812
2013-06-17Identification of new colorectal cancer susceptibility genes FINDING CRC GENEScoordinator230.3901
2012-06-01Mechanisms and Targeting Stromal Contribution to Tumour Invasion and Metastasis STROMALIGNparticipant1.495.7961
2011-09-01Role of human papillomavirus infection and other co-factors in the aetiology of head and neck cancer in India and Europe HPV-AHEADparticipant2.999.94611
2011-05-01Use of adoptive T cell transfer in combination with oncolytic adenoviruses for cancer treatment Cancer therapiescoordinator223.6702
2010-05-01health-economic modelling of PREvention strategies for Hpv-related Diseases in European CounTries PREHDICTparticipant2.963.53213

Alias institution names:

  • INSTITUT CATALA D'ONCOLOGIA